Viewing data from:

ZUMANDIMINE

ANDA

DROSPIRENONE; ETHINYL ESTRADIOL | A209407 | AUROBINDO PHARMA LTD

1 strength0 unique patents0 unique exclusivities

Reference Listed Drug: YASMIN(TE code: AB)

Medicare Part D Spending

CMS annual spending data for Zumandimine (2023)

Total Spending

$8K

Total Claims

241

Beneficiaries

Avg Cost/Unit

$0.76

Spending Trend

$7K(2020)→$27K(2021)→$21K(2022)→$8K(2023)

YoY Change:-20.0%

5yr CAGR:-6.1%

Source: CMS Medicare Part D Spending by Drug (2023). Shows gross drug cost under Part D.

Products (1)

#001 — 3MG;0.03MG

0 patents0 exclusivities▴

TABLET;ORAL-28 | Approved: Mar 26, 2018

No patent or exclusivity listings for this strength.